IN10018 Combination Therapy in Treatment-naïve ES-SCLC

Clinical trial NCT06030258 · RECRUITING

Trial details

NCT number: NCT06030258
Sponsor: InxMed (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage

Start date: 2023-10-30
Primary completion: 2025-12-24
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.